Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.Sweta Chekuri, Brett L. Houston, Lucy Z. Kornblith et al.|Bristol Research (University of Bristol)|2021Cited by 589
The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guidelineBram Rochwerg, Karen E. A. Burns, Sharon Einav et al.|Intensive Care Medicine|2020Cited by 413
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M. Arabi, Anthony Gordon, Lennie Derde et al.|Intensive Care Medicine|2021Cited by 100
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C. Goligher, Allen Cheng, Patrick R. Lawler et al.|JAMA|2023Cited by 98
Noninvasive respiratory support following extubation in critically ill adults: a systematic review and network meta-analysisShannon M. Fernando, Bram Rochwerg, Alexandre Tran et al.|Intensive Care Medicine|2021Cited by 94